Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors

Lin Li, Haodong Xu, Betsy O. Spaulding, Liang Cheng, Rochelle Simon, Jorge L. Yao, P. Anthony di Sant'Agnese, Patricia A. Bourne, Jiaoti Huang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

RNA-binding protein IMP3 is a KH-domain-containing protein and a member of the insulin-like growth factor messenger RNA-binding protein family. It is identical to K-homology protein overexpressed in cancer that was identified through screening for genes differentially expressed between benign pancreatic tissue and pancreatic cancer. Several studies have shown that IMP3 is associated with aggressive and advanced tumors in various organs. We studied the expression of IMP3 in benign urothelium and urothelial tumors by immunohistochemistry. The expression pattern of IMP3 was further compared with that of p53 and p16. Our study shows that IMP3 is generally not expressed in benign urothelium or low-grade urothelial tumors including urothelial dysplasia, papillary urothelial neoplasm of low malignant potential, and low-grade papillary urothelial carcinoma. The expression of IMP3 is significantly increased in high-grade urothelial tumors including high-grade papillary urothelial carcinoma, urothelial carcinoma in situ, and invasive urothelial carcinoma. Expression of IMP3 in urothelial tumors parallels the accumulation of nuclear p53, although there is not always a one to one correlation. In contrast, expression of p16 in the different groups of urothelial tumors is more variable. Urothelial carcinomas with invasion of muscularis propria appear to express IMP3 more frequently than lower-stage tumors. These findings suggest that IMP3 may be involved in the progression of urothelial tumors from low grade to high grade in both papillary and flat lesions. Immunohistochemical detection of the combined expression of IMP3 and p53 is useful in the diagnosis of high-grade urothelial tumors, particularly in small, superficial materials.

Original languageEnglish
Pages (from-to)1205-1211
Number of pages7
JournalHuman Pathology
Volume39
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

Urothelium
RNA-Binding Proteins
Neoplasms
Papillary Carcinoma
Carcinoma
Carcinoma in Situ
Somatomedins
Pancreatic Neoplasms
Immunohistochemistry

Keywords

  • Bladder
  • IMP3
  • p16
  • p53
  • Urothelial neoplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. / Li, Lin; Xu, Haodong; Spaulding, Betsy O.; Cheng, Liang; Simon, Rochelle; Yao, Jorge L.; di Sant'Agnese, P. Anthony; Bourne, Patricia A.; Huang, Jiaoti.

In: Human Pathology, Vol. 39, No. 8, 08.2008, p. 1205-1211.

Research output: Contribution to journalArticle

Li, L, Xu, H, Spaulding, BO, Cheng, L, Simon, R, Yao, JL, di Sant'Agnese, PA, Bourne, PA & Huang, J 2008, 'Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors', Human Pathology, vol. 39, no. 8, pp. 1205-1211. https://doi.org/10.1016/j.humpath.2007.12.012
Li, Lin ; Xu, Haodong ; Spaulding, Betsy O. ; Cheng, Liang ; Simon, Rochelle ; Yao, Jorge L. ; di Sant'Agnese, P. Anthony ; Bourne, Patricia A. ; Huang, Jiaoti. / Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. In: Human Pathology. 2008 ; Vol. 39, No. 8. pp. 1205-1211.
@article{35d0c77e97ee4c7490eca221cf3e1eed,
title = "Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors",
abstract = "RNA-binding protein IMP3 is a KH-domain-containing protein and a member of the insulin-like growth factor messenger RNA-binding protein family. It is identical to K-homology protein overexpressed in cancer that was identified through screening for genes differentially expressed between benign pancreatic tissue and pancreatic cancer. Several studies have shown that IMP3 is associated with aggressive and advanced tumors in various organs. We studied the expression of IMP3 in benign urothelium and urothelial tumors by immunohistochemistry. The expression pattern of IMP3 was further compared with that of p53 and p16. Our study shows that IMP3 is generally not expressed in benign urothelium or low-grade urothelial tumors including urothelial dysplasia, papillary urothelial neoplasm of low malignant potential, and low-grade papillary urothelial carcinoma. The expression of IMP3 is significantly increased in high-grade urothelial tumors including high-grade papillary urothelial carcinoma, urothelial carcinoma in situ, and invasive urothelial carcinoma. Expression of IMP3 in urothelial tumors parallels the accumulation of nuclear p53, although there is not always a one to one correlation. In contrast, expression of p16 in the different groups of urothelial tumors is more variable. Urothelial carcinomas with invasion of muscularis propria appear to express IMP3 more frequently than lower-stage tumors. These findings suggest that IMP3 may be involved in the progression of urothelial tumors from low grade to high grade in both papillary and flat lesions. Immunohistochemical detection of the combined expression of IMP3 and p53 is useful in the diagnosis of high-grade urothelial tumors, particularly in small, superficial materials.",
keywords = "Bladder, IMP3, p16, p53, Urothelial neoplasia",
author = "Lin Li and Haodong Xu and Spaulding, {Betsy O.} and Liang Cheng and Rochelle Simon and Yao, {Jorge L.} and {di Sant'Agnese}, {P. Anthony} and Bourne, {Patricia A.} and Jiaoti Huang",
year = "2008",
month = "8",
doi = "10.1016/j.humpath.2007.12.012",
language = "English",
volume = "39",
pages = "1205--1211",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors

AU - Li, Lin

AU - Xu, Haodong

AU - Spaulding, Betsy O.

AU - Cheng, Liang

AU - Simon, Rochelle

AU - Yao, Jorge L.

AU - di Sant'Agnese, P. Anthony

AU - Bourne, Patricia A.

AU - Huang, Jiaoti

PY - 2008/8

Y1 - 2008/8

N2 - RNA-binding protein IMP3 is a KH-domain-containing protein and a member of the insulin-like growth factor messenger RNA-binding protein family. It is identical to K-homology protein overexpressed in cancer that was identified through screening for genes differentially expressed between benign pancreatic tissue and pancreatic cancer. Several studies have shown that IMP3 is associated with aggressive and advanced tumors in various organs. We studied the expression of IMP3 in benign urothelium and urothelial tumors by immunohistochemistry. The expression pattern of IMP3 was further compared with that of p53 and p16. Our study shows that IMP3 is generally not expressed in benign urothelium or low-grade urothelial tumors including urothelial dysplasia, papillary urothelial neoplasm of low malignant potential, and low-grade papillary urothelial carcinoma. The expression of IMP3 is significantly increased in high-grade urothelial tumors including high-grade papillary urothelial carcinoma, urothelial carcinoma in situ, and invasive urothelial carcinoma. Expression of IMP3 in urothelial tumors parallels the accumulation of nuclear p53, although there is not always a one to one correlation. In contrast, expression of p16 in the different groups of urothelial tumors is more variable. Urothelial carcinomas with invasion of muscularis propria appear to express IMP3 more frequently than lower-stage tumors. These findings suggest that IMP3 may be involved in the progression of urothelial tumors from low grade to high grade in both papillary and flat lesions. Immunohistochemical detection of the combined expression of IMP3 and p53 is useful in the diagnosis of high-grade urothelial tumors, particularly in small, superficial materials.

AB - RNA-binding protein IMP3 is a KH-domain-containing protein and a member of the insulin-like growth factor messenger RNA-binding protein family. It is identical to K-homology protein overexpressed in cancer that was identified through screening for genes differentially expressed between benign pancreatic tissue and pancreatic cancer. Several studies have shown that IMP3 is associated with aggressive and advanced tumors in various organs. We studied the expression of IMP3 in benign urothelium and urothelial tumors by immunohistochemistry. The expression pattern of IMP3 was further compared with that of p53 and p16. Our study shows that IMP3 is generally not expressed in benign urothelium or low-grade urothelial tumors including urothelial dysplasia, papillary urothelial neoplasm of low malignant potential, and low-grade papillary urothelial carcinoma. The expression of IMP3 is significantly increased in high-grade urothelial tumors including high-grade papillary urothelial carcinoma, urothelial carcinoma in situ, and invasive urothelial carcinoma. Expression of IMP3 in urothelial tumors parallels the accumulation of nuclear p53, although there is not always a one to one correlation. In contrast, expression of p16 in the different groups of urothelial tumors is more variable. Urothelial carcinomas with invasion of muscularis propria appear to express IMP3 more frequently than lower-stage tumors. These findings suggest that IMP3 may be involved in the progression of urothelial tumors from low grade to high grade in both papillary and flat lesions. Immunohistochemical detection of the combined expression of IMP3 and p53 is useful in the diagnosis of high-grade urothelial tumors, particularly in small, superficial materials.

KW - Bladder

KW - IMP3

KW - p16

KW - p53

KW - Urothelial neoplasia

UR - http://www.scopus.com/inward/record.url?scp=47649122801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47649122801&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2007.12.012

DO - 10.1016/j.humpath.2007.12.012

M3 - Article

C2 - 18547613

AN - SCOPUS:47649122801

VL - 39

SP - 1205

EP - 1211

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -